Journal:
:journal of cellular and molecular anesthesia
0
taregh bamedi department of parasitology, iranshahr university of medical sciences, iranshahr, iran
ghazaleh dadashizadeh department of hematology and blood transfusion, school of medicine, mashhad university of medical sciences, mashhad, iran
afsaneh sarabandi department of nursing, faculty of medical sciences, islamic azad university, zahedan branch, zahedan, iran
shadi tabibian department of hematology and blood transfusion, school of allied medicine, iran university of medical sciences, tehran, iran
mahmood shams department of laboratory sciences, paramedical faculty, babol university of medical sciences, babol
akbar dorgalaleh department of hematology and blood transfusion, school of allied medicine, iran university of medical sciences, tehran, iran
inhibitor development is a lifelong challenge for patients with bleeding disorders who received replacement therapy. most commonly, inhibitor formation was observed in hemophilia a patients but patients with rare bleeding disorders (rbd) especially patients with deficiency of factor xiii (fxiii) and factor v (fv) can develop an inhibitor against exogenous factors. several factors considered as ...